Prévalence de l’hyperuricémie chez les patients obèses : à propos de 230 cas

Motaib, Imane; Bennis, S.; Elmghari, G.; Ansari, N. El

doi:10.1016/j.ando.2013.07.791

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Dyslipidemia is a frequent metabolic complication of obesity [12]. In our series, dyslipidemia was found in 68.42% of cases, a figure similar to that found in the series by Serra et al (69.50%) [7], although it was predominantly higher than in the study by Pinto et al (32.63%) [13].…”

Section: Discussionsupporting

confidence: 88%

“…However, 13.15% of our patients, compared with 32.63% of patients in the Spanish series [7], had an elevated GFR. Several studies have demonstrated the presence of glomerular hyper-filtration in obese patients [13,14,15,16,17], and its expression in absolute values (ml/min) in most subjects gives values 50% higher than those observed in normo-weight subjects. It should also be noted that none of the patients in our series had a GFR < 60 ml/min/1.73m2, as was the case in the Spanish series by Serra et al [7], while in another Dutch series, 3.64% of cases had a decreased GFR compared with 6.57% of cases with glomerular hyper-filtration [13].…”

Section: Discussionmentioning

confidence: 95%

See 1 more Smart Citation

Obesity and chronic kidney disease: What specificity of this association and what epidemiological profile? A prospective study

Hamza EL JADI,

Hicham BAIZRI

2024

World J. Adv. Res. Rev.

View full text Add to dashboard Cite

Obesity is accompanied by chronic diseases including cardiometabolic diseases. Obesity is also an independent factor of renal risk that deserves to be taken into account. The aims of our work were to determine the prevalence of chronic kidney disease related to obesity independently of all other usual risk factors and to describe its epidemiological characteristics in our population. We conducted a prospective descriptive and analytic study over a period of 12 months in 38 patients over 18 years of age, with a BMI> 30 Kg / m² and without diabetes, hypertension, or other apparent cause chronic kidney disease, collected at the consulting service of the Military Hospital Avicenna of Marrakech, Morocco. The average age of our patients was 38 years with a female predominance (sex ratio (m/w) of 0.80). The average BMI was 35.35 kg / m². Dyslipidemia was found in 68.42% of patients, hyperuricemia in 18.42%, microalbuminuria in 13.15%, macroalbuminuria in 7.89% and hematuria in 2.6%. Glomerular hyperfiltration was present in 13.15% of cases and no patient had a GFR <60 ml / min / 1.73m². The prevalence of chronic kidney disease among obese people in our population was 10.5%. Older obese patients with high BMI, hypertriglyceridemia, hypercholesterolemia, and hyper LDLemia were the most affected, with statistically significant differences between the 2 groups of patients with and without chronic kidney disease (P <0.05). Our study warn of the need for cost-effective and well-adapted prevention measures to reverse the growing epidemic of obesity in the world.

show abstract

Section: Discussionsupporting

confidence: 88%